STEK Stock Analysis
ST
Uncovered
Stemtech Corp is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Stemtech Corp. engages in the development of nutritional supplements. The company is headquartered in Miramar, Florida. The company went IPO on 2014-09-15. Stemtech is also known as Stem Cell Nutrition Company. The firm's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The firm markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem (Oral Health Care), and D-Fuze. Stemtech has three reportable operating segments: North America, Latin America (including subsidiaries in Mexico and Ecuador) and Asia.